- Filed
- Mar 9, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 5, 2026 | 36.96M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 37.24M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 37.31M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 37.36M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 37.33M sh |
| Stock Repurchased | Q3 2026 · Jan 31, 2026 | $137.26M |
| Stock Repurchased | Q3 2026 · Jan 31, 2025 | $734K |
| Dividends Paid | Q3 2026 · Jan 31, 2026 | $62.04M |
| Dividends Paid | Q3 2026 · Jan 31, 2025 | $53.75M |
| Capex | Q3 2026 · Jan 31, 2026 | $464.84M |
| Capex | Q3 2026 · Jan 31, 2025 | $325.5M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | $979.03M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | $757M |
| Long Term Debt | Q3 2026 · Jan 31, 2026 | $2.33B |
| Long Term Debt | Q3 2026 · Apr 30, 2025 | $2.41B |
| Short Term Debt | Q3 2026 · Jan 31, 2026 | $101.46M |
| Short Term Debt | Q3 2026 · Apr 30, 2025 | $94.93M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $465.02M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | $326.66M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $3.85B |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $3.81B |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $3.64B |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $3.51B |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $3.42B |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $3.34B |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | $3.16B |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | $3.02B |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $1.1B |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $1.1B |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $4.73B |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $4.7B |
| Current Assets | Q3 2026 · Jan 31, 2026 | $1.15B |
| Current Assets | Q3 2026 · Apr 30, 2025 | $1.01B |
| Total Assets | Q3 2026 · Jan 31, 2026 | $8.59B |
| Total Assets | Q3 2026 · Apr 30, 2025 | $8.21B |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $3.49 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $14.79 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $2.33 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $12.01 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $3.51 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $14.87 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $2.35 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $12.08 |
| Net Income | Q3 2026 · Jan 31, 2026 | $130.07M |
| Net Income | Q3 2026 · Jan 31, 2026 | $551.76M |
| Net Income | Q3 2026 · Oct 31, 2025 | $206.34M |
| Net Income | Q3 2026 · Jul 31, 2025 | $215.36M |
| Net Income | Q3 2026 · Jan 31, 2025 | $87.1M |
| Net Income | Q3 2026 · Jan 31, 2025 | $448.21M |
| Net Income | Q3 2026 · Oct 31, 2024 | $180.92M |
| Net Income | Q3 2026 · Jul 31, 2024 | $180.2M |
| Revenue | Q3 2026 · Jan 31, 2026 | $3.92B |
| Revenue | Q3 2026 · Jan 31, 2026 | $12.99B |
| Revenue | Q3 2026 · Jan 31, 2025 | $3.9B |
| Revenue | Q3 2026 · Jan 31, 2025 | $11.95B |